Dengue
Dengue
Dengue
Pharmacy
Topic: Dengue
This viral infection causes a severe flu-like illness and, sometimes causes a
potentially lethal complication called severe dengue which generally affects children
and infants.
Dengue fever is also known asbreak bonefever. This is most rapidly spreading
mosquito borne viral disease in the world.
Dengue viruse is spread into people through bite of an infected Aedes species (Ae.
aegypti or Ae. albopictus) mosquito.
Humans are primary host and the incubation period is about 4-7 days.
Mosquitoes become infected when they bite a person infected with the
virus. Infected mosquitoes then can spread the virus to other people
through bites.
Heart failure, kidney failure due to the continuous bleeding in the body, causing circulatory system
disturbances, it leads to heart failure. When the heart is not able to pump blood, plasma fluid appears
continuously, causing the pericardium to overflow, causing stasis. This causes the heart and circulatory
system to be severely affected, causing heart failure and bleeding. The kidneys also have to work at full
capacity to excrete plasma in the urine, which can lead to acute kidney failure.
Mother-to-child viral transmission during childbirth:Dengue virus transmission from mother to child occurs
during natural child birth in dengue-infected mothers. In addition, mothers who contract dengue fever during
pregnancy are at a higher risk of premature birth, low birth weight babies, fetal death, and mother-to-child
viral transmission.
Coma during hemorrhage, plasma fluid can pool in the meninges through the vessel walls causing cerebral
edema and neurological syndromes leading to coma. This is the most severe complication of dengue fever.
Treatment
1. Primary treatment – pain relievers, fluid therapy and in some cases close care from hospital.
2. Drinking plenty of water may help a patients from getting dehydrated also it can avoid vomiting and
high fever.
4. Avoid pain reliever which increases bleeding complication i.e NSAIDS such as aspirin, ibuprofen as
it may increase chances of internal bleeding.
5. In case of severe dengue fever the patient may also IV fluids, electrolyte replacement and
transfusion to replace blood loss.
6. The first vaccine of dengue fever was developed by Sanoli Pasteur. This Dengvaxiaâ
(CYD_TDV) vaccine was licensed in December 2015 and has now approved by regulatory authorities in
about 20 countries.
Prevention
• The infected individual should be isolated under bed nets for the first few
days to protect against mosquitoes.